MTND4P7

Across TCGA pan-cancer cohorts, MTND4P7 RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated MTND4P7 data layer.

The strongest signal is observed in skin cutaneous melanoma (SKCM), where higher MTND4P7 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated MTND4P7 expression acts as an unfavorable survival marker, although some lineages such as UCS and ACC show a favorable association.

SKCM, THCA, and PCPG are the cancer types where MTND4P7 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
SKCM	DFS	Tertile	III,IV	0.161	0.564	<.001	72	view →
THCA	OS	Tertile	II,III,IV	0.171	0.824	<.001	21	view →
PCPG	OS	Tertile	All	0.786	0.963	<.001	18	view →
UCS	OS	Tertile	All	0.865	0.284	.036	6	view →
ACC	OS	Tertile	II,III,IV	1.000	0.732	.047	3	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

MTND4P7–SKCM (DFS)

Open the SKCM breakdown →